Add-on MEmaNtine to Dopamine Modulation to Improve Negative Symptoms at First Psychosis

Clinical trial NCT04789915 · RECRUITING

Trial details

NCT number: NCT04789915
Sponsor: Bjorn H. Ebdrup
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Psychosis Negative Symptoms With Primary Psychotic Disorder

Start date: 2021-05-26
Primary completion: 2025-07-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.